Valsts valodas centra izstrādātie medicīnas zinātņu, farmācijas un veterinārmedicīnas termini

Konteksts: [..] For gene and somatic cell therapy medicinal products, it is recognised that conventional requirements as laid down inModule 4 for non-clinical testing of medicinal products may not always be appropriate due to unique and diverse structural and biological properties of the products in question, including high degree of species specificity, subject specificity, immunological barriers and differences in pleiotropic responses [..]
Avots: Commission directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use (Text with EEA relevance)